METHYCLOTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Methyclothiazide patents expire, and what generic alternatives are available?
Methyclothiazide is a drug marketed by Chartwell Rx, Ivax Pharms, Mylan, Mylan Pharms Inc, Par Pharm, Usl Pharma, and Watson Labs. and is included in fifteen NDAs.
The generic ingredient in METHYCLOTHIAZIDE is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHYCLOTHIAZIDE?
- What are the global sales for METHYCLOTHIAZIDE?
- What is Average Wholesale Price for METHYCLOTHIAZIDE?
Summary for METHYCLOTHIAZIDE
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 15 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Patent Applications: | 4,128 |
Formulation / Manufacturing: | see details |
DailyMed Link: | METHYCLOTHIAZIDE at DailyMed |
![METHYCLOTHIAZIDE drug patent expirations Drug patent expirations by year for METHYCLOTHIAZIDE](/p/graph/s/t/METHYCLOTHIAZIDE-patent-expirations.png)
Medical Subject Heading (MeSH) Categories for METHYCLOTHIAZIDE
Anatomical Therapeutic Chemical (ATC) Classes for METHYCLOTHIAZIDE
US Patents and Regulatory Information for METHYCLOTHIAZIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Rx | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 089835-001 | Aug 18, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Par Pharm | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 089135-001 | Feb 12, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ivax Pharms | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 087786-001 | May 18, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |